Abortion by Mail

Steven Mosher
written by Samantha Harris
February 20, 2024
Reproduced with Permission
Population Research Institute

The U.S. Supreme Court will soon decide the fate of tens, perhaps hundreds, of thousands of unborn children. These are the children who, following a death sentence imposed during a single pro forma telephone call, will be executed by a poison pill that conveniently arrives by mail a few days later.

We're talking about dangerous telemedicine abortions, carried out by mailing of mifepristone to any terrified teenage girl who calls an abortion hotline. On the one side are those who accuse the FDA of reckless disregard of the safety of mother (and child) in approving these practices and want the court to stop telemedicine abortions. On the other side is Danco Laboratories, which distributes the abortion pill, and the radically pro-abortion Biden administration, both of whom want to continue to push the pill. Oral arguments will take place on March 26, 2024.

When the mifepristone abortion pill was first approved by the Food and Drug Agency in 2000, the agency put severe restrictions on its use. It could only be prescribed by a physician to a woman who was less than 7 weeks pregnant, it had to be administered by a physician, and a minimum of three in-person office visits were required in the course of the chemical abortion. In the years since, under Obama and now Biden, the gestational limit has been pushed back to 10 weeks and the requirement for office visits has been replaced by the phone chat with a nurse.

There has been one additional--and very troubling-change. While physicians who administered the abortion pill were at first required to report all adverse events, even minor ones, to the FDA, this is no longer the case. Under Biden, the agency has bizarrely decided that the only adverse effect that it now wants to hear about is death. Let us know if the abortion pill kills someone, the FDA is in effect saying, but don't bother us with reports about the hemorrhages, infections, and incomplete abortions that otherwise occur.

Given that the FDA itself admits that one in 25 girls will end up in the emergency room after taking the abortion pill, all of these changes seem reckless in the extreme.

The question before the court is whether or not to end mail-order abortions and reinstate the much more restrictive 2000 regulations on the abortion pill's use.

The Supreme Court will hopefully consider one additional factor as well. Legal action against Danco recently forced the drug company to reveal where the Mifepristone tablets it is sending all over the United States were actually manufactured. It turns out that they come from China.

Is anyone bothered by the fact that a country infamous for its long-running population control program, which resulted in the deaths of hundreds of millions of unborn children, should be secretively sending over drugs to abort American children?

PRI's president Steven Mosher is. The well-known China expert warns that "Americans need to understand that the Chinese Communist Party is engaged in unrestricted warfare against the United States. Just as it allows fentanyl and its precursors to be manufactured in China and sent to the U.S. to kill 100,000 Americans each year, so it allows another deadly drug, mifepristone, to be manufactured and sent over to kill hundreds of thousands more. Aside from the deadly nature of the drug, there is the issue of quality control, which is a problem with many Chinese products. These considerations, in addition to the regulatory issues, will hopefully convince the Supreme Court to restrict its use."

When the FDA fast-tracked the approval of mifepristone in 2000, it did not conduct due diligence. Instead, it apparently decided that promoting abortion was more important than the health and safety of women and children. Unfortunately, the Supreme Court has already rejected a request to completely revoke the FDA's approval of the drug.

The legal battle over the abortion pill now concerns the regulations governing its use, which have been progressively relaxed under pro-abortion pressure over the years. A 2016 change by the Obama administration increased the gestational age limit from 7 to 10 weeks and allowed a broadly defined set of "healthcare providers" to prescribe the drug.

The Biden administration pushed the envelope even further. A 2021 FDA decision allowed the pills to be dispensed by mail. Then in 2023, even more retail and online pharmacies were allowed to carry it.

The current case before the Supreme Court originated with the decision of a federal judge in Texas to suspend the FDA's approval of mifepristone. In a ruling issued on April 7, 2023, the judge wrote that "[the] FDA abandoned its safety proposals and acquiesced to the objections of the Population Council and Danco."

PRI has been exposing the dangers of the abortion drug Mifepristone for many years, the safety and quality control issues only highlighted by the recent reveal that the drug is of Chinese origin. Mr. Mosher states, "There is an immense significance that the abortion pill comes from America's chief geopolitical rival which is waging unrestricted warfare against us in so many ways."

As this hearing by the Supreme Court approaches, the truth of what these abortion pills are and where they come from is vital. Prayers for the protection of America's youngest--in the womb--are more important than ever.